Here are the 10-Q quarterly reports from Preaxia Health Care Pymnt (PAXH) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PAXH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAXH filings page.
PreAxia Health Care Payment Systems Inc. reported a net loss of $206,876 for the three months ended August 31, 2026, compared with $745,208 in the three months ended August 31, 2025, as restated; revenue was $0 in both periods. Net cash provided by operating activities was $22,096. Cash and cash equivalents were $141,579 as of August 31, 2026, compared with $1,003 as of May 31, 2026.
The company reported a working capital deficit of $1,187,960 and a stockholders’ deficit of $543,336 as of August 31, 2026. Management said cash would not meet working-capital requirements for the next twelve-month period and estimated a $1 million funding need over that period, including approximately $300,000 for arms-length creditors and an additional $700,000 to complete its business plan. The company said these factors raise substantial doubt about its ability to continue as a going concern within one year of the date the financial statements are issued. Management also concluded that disclosure controls and procedures were not effective as of August 31, 2026.
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. (PAXH) filed an amended Form 10‑Q/A2 for the quarter ended August 31, 2025, restating its prior 10‑Q and 10‑Q/A after management filed a notice of non‑reliance. The restatement reclassifies three management and consulting contracts from prepaid expenses to warrants, recognizes additional stock issuances and debt conversions, and adjusts related‑party loans and payables.
The company reported no revenue and a net loss of $745,208 for the quarter, driven by $576,134 of operating expenses and a $169,143 loss on debt settlement, compared with a $4,627 loss a year earlier. Extensive equity issuances and conversions increased common shares outstanding to 43,514,782 and improved shareholders’ deficit from $(2,341,169) at May 31, 2025 to $(605,757), while total liabilities fell from $2,341,169 to $736,042. The company discloses substantial doubt about its ability to continue as a going concern, has material weaknesses in disclosure controls, and expects to rely on new capital, related‑party financing and further equity‑based compensation as it develops its healthcare payment and personal finance software.
PreAxia Health Care Payment Systems (PAXH) filed a 10‑Q/A to correct its cover-page share count and a subsequent event. The amendment updates outstanding common shares to 54,314,782 as of October 15, 2025, and notes that 34,547,084 shares were issued to settle prior-quarter stock subscriptions.
For the quarter ended August 31, 2025, PreAxia reported $0 revenue and a net loss of $875,134. Operating expenses were driven by research and development $391,263, management $387,500, and consulting $65,000. Cash was $130,285 with a working capital deficit of $232,678. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
Equity activity included $3,651,222 in stock subscriptions at quarter-end and a $200,000 private placement for 800,000 shares in August, with shares issued in October. Internal controls were deemed not effective as of the quarter end.
PreAxia Health Care Payment Systems Inc. filed its 10‑Q reporting no revenue and a net loss of $875,134 for the three months ended August 31, 2025. Operating expenses were $875,203, driven by research and development $391,263, management and labor $387,500, consulting $65,000, and professional fees $23,200. Basic and diluted loss per share was $(0.04) on a weighted average of 19,767,698 shares.
As of August 31, 2025, cash was $130,285 and working capital deficit was $232,678. Shareholders’ equity was $427,322 with an accumulated deficit of $6,085,524. The company recognized stock subscriptions for services and debt, including $1,800,000 for consulting and management (40% expensed at grant) and $1,643,397 to convert debt. Two related‑party notes were converted on June 30, 2025 at $0.10 per share for 4,668,170 and 10,587,600 shares, and a private placement brought in $200,000 for 800,000 shares in August 2025.
Management disclosed “substantial doubt” about the company’s ability to continue as a going concern and reported disclosure controls and procedures were not effective as of August 31, 2025.